OLMA — OLEMA PHARMACEUTICALS INC

Ownership history in BVF INC/IL · 21 quarters on record

This page tracks every 13F SEC filing in which BVF INC/IL reported a position in OLEMA PHARMACEUTICALS INC (OLMA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position

12.6% (2020 Q4)

Avg. % of fund

3.3%

First filed

2020 Q4

Last filed

2025 Q4

Quarters held

21

Quarter	Action	Shares	Change	Chg %	% of Fund	Mkt Value	Price (EOQ)
2025 Q4	UNCHANGED	5,295,893	—	0%	4.46%	$132.4M	$25.00
2025 Q3	UNCHANGED	5,295,893	—	0%	2.10%	$51.8M	$9.79
2025 Q2	UNCHANGED	5,295,893	—	0%	0.81%	$22.6M	$4.26
2025 Q1	REDUCED	5,295,893	-420,000	-7.3%	0.81%	$19.9M	$3.76

% of Fund (quarterly) OLMA price (monthly, adj. close)

Other funds also holding OLMA

As of 2025 Q4 — sorted by position size

Bain Capital Life Sciences Investors, LLC 3Y 7Y 16.29% Logos Global Management LP 3Y 4.85% Paradigm Biocapital Advisors LP 3Y 4.81% Birchview Capital, LP 3Y 7Y 3.94% Lightspeed Management Company, L.L.C. 3.46% Cormorant Asset Management, LP 3Y 7Y 3.18% KINGDON CAPITAL MANAGEMENT, L.L.C. 3Y 7Y 2.83% Siren, L.L.C. 2.46% First Turn Management, LLC 1.76% HighVista Strategies LLC 3Y 7Y 1.55%

← Back to BVF INC/IL Holdings